Atlas Trials

Thalidomide in Mucosa Associated Lymphoid Tissue (MALT) Lymphoma Patients

Clinical trial NCT00373646 · COMPLETED

Trial details

NCT number
NCT00373646
Sponsor
Medical University of Vienna
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
MALT Lymphoma
Start date
2006-06-01
Primary completion
2009-01-01
Enrollment
8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.